Working... Menu

Brentuximab Vedotin in the Elderly Hodgkin Lymphoma Patients at First Relapse or With Primary Refractory Disease. (FIL_BVHD01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02227433
Recruitment Status : Active, not recruiting
First Posted : August 28, 2014
Last Update Posted : February 8, 2019
Information provided by (Responsible Party):
Fondazione Italiana Linfomi ONLUS

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : April 3, 2018
  Estimated Study Completion Date : April 2019